[go: up one dir, main page]

DK2964248T3 - Behandling af og profylakse for stråledermatitis - Google Patents

Behandling af og profylakse for stråledermatitis Download PDF

Info

Publication number
DK2964248T3
DK2964248T3 DK14714943.9T DK14714943T DK2964248T3 DK 2964248 T3 DK2964248 T3 DK 2964248T3 DK 14714943 T DK14714943 T DK 14714943T DK 2964248 T3 DK2964248 T3 DK 2964248T3
Authority
DK
Denmark
Prior art keywords
radiatheratitis
prophylaxy
treatment
Prior art date
Application number
DK14714943.9T
Other languages
English (en)
Inventor
Mark Lait
George Bishop
Original Assignee
Water Jel Europe Llp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Water Jel Europe Llp filed Critical Water Jel Europe Llp
Application granted granted Critical
Publication of DK2964248T3 publication Critical patent/DK2964248T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018Hydrolysed proteins; Derivatives thereof from animals from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK14714943.9T 2013-03-06 2014-03-06 Behandling af og profylakse for stråledermatitis DK2964248T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361773225P 2013-03-06 2013-03-06
GB201304041A GB201304041D0 (en) 2013-03-06 2013-03-06 Treatment and prophylaxis of radiation dermatitis
PCT/EP2014/054319 WO2014135622A2 (en) 2013-03-06 2014-03-06 Treatment and prophylaxis of radiation dermatitis

Publications (1)

Publication Number Publication Date
DK2964248T3 true DK2964248T3 (da) 2019-08-26

Family

ID=48142536

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14714943.9T DK2964248T3 (da) 2013-03-06 2014-03-06 Behandling af og profylakse for stråledermatitis

Country Status (18)

Country Link
US (3) US10098912B2 (da)
EP (1) EP2964248B1 (da)
CN (1) CN105120882A (da)
AU (1) AU2014224619B2 (da)
CA (1) CA2903647C (da)
CY (1) CY1122640T1 (da)
DK (1) DK2964248T3 (da)
ES (1) ES2742851T3 (da)
GB (1) GB201304041D0 (da)
HK (1) HK1218722A1 (da)
HR (1) HRP20191490T1 (da)
HU (1) HUE045730T2 (da)
LT (1) LT2964248T (da)
PL (1) PL2964248T3 (da)
PT (1) PT2964248T (da)
RS (1) RS59160B1 (da)
SI (1) SI2964248T1 (da)
WO (1) WO2014135622A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD863671S1 (en) 2015-10-07 2019-10-15 William James Reimann Water pipe
CN105796831A (zh) * 2016-04-19 2016-07-27 北京欣普迪生物科技有限公司 医用射线防护剂及其制备方法
DE102018201598A1 (de) * 2018-02-02 2019-08-08 Beiersdorf Ag Stabile Wundheilsalbe
US11267788B2 (en) 2020-07-16 2022-03-08 Dermavant Sciences GmbH Isoquinoline compounds and their use in treating AhR imbalance
CN114191597B (zh) * 2021-12-16 2022-11-25 湖南银华棠医药科技有限公司 一种皮肤创面修复用液体敷料及其制备方法和用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0850043T3 (da) * 1995-08-31 2002-03-25 Procter & Gamble Hudkonditioneringssammensætning, der indeholder siliconegummi, en blanding af polyoxyethylener og glycerolforbindelse
US5736128A (en) * 1996-05-14 1998-04-07 Isp Investments Inc. Cosmetic composition for rejuvenation of skin without skin irritation
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
KR100885948B1 (ko) * 2002-07-02 2009-02-26 주식회사 포스코 래이들 경동스탠드 새들의 슬래그 제거장치
KR100500172B1 (ko) * 2002-10-02 2005-07-07 주식회사 대웅 사람 표피성장인자 및 락토카인을 포함하는 피부 보호용화장료 조성물
KR101158266B1 (ko) * 2003-11-03 2012-06-19 시바 홀딩 인코포레이티드 안정화된 바디 케어 제품, 가정용품, 직물원료 및 직물
DE102004003436A1 (de) * 2004-01-21 2005-08-11 Beiersdorf Ag Dünnflüssige O/W-Emulsion II
US20050175559A1 (en) * 2004-02-10 2005-08-11 Pcr Technology Holdings, Lc Method and preparation for reducing skin hyperpigmentation
EP1865920A1 (en) * 2005-04-04 2007-12-19 Bioartificial Gel Technologies Inc. Prevention and treatment of radiation dermatitis
US20070248555A1 (en) * 2006-04-20 2007-10-25 Watson Dana M Composition and method for managing redness of skin associated with dermatological condition
CN101505781A (zh) * 2006-06-22 2009-08-12 阿根尼克斯有限公司 作为辐射防护物质的乳铁蛋白
JP2010513289A (ja) * 2006-12-15 2010-04-30 ザ プロクター アンド ギャンブル カンパニー スキンケア組成物
FR2937866B1 (fr) * 2008-10-30 2010-11-26 Natura Cosmeticos Sa Complexe antioxydant, compositions cosmetiques et pharmaceutiques contenant ledit complexe et utilisation dudit complexe
GB0822823D0 (en) * 2008-12-15 2009-01-21 Dow Corning Silicone oi-in-water emulsions
ES2354098B1 (es) * 2009-08-12 2012-01-31 Jose Andres Prieto Alonso Preparado líquido de afeitado.
FR2950054B1 (fr) * 2009-09-16 2011-10-07 Chanel Parfums Beaute Composition cosmetique comprenant un derive de leucodopachrome
EP2533753B1 (en) * 2009-11-10 2022-07-06 Laboratory Skin Care, Inc. Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles, and methods of making and using the same
US9629856B2 (en) * 2010-03-03 2017-04-25 Anteis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
CA2852210C (en) * 2010-10-26 2019-04-02 Quinnova Pharmaceuticals, Inc. Composition and method for treating wounds
US20130209378A1 (en) * 2012-02-09 2013-08-15 The Dial Corporation Skin conditioning and lubricating creme, and method of making and using same

Also Published As

Publication number Publication date
CA2903647A1 (en) 2014-09-12
RS59160B1 (sr) 2019-10-31
WO2014135622A3 (en) 2014-10-30
US10098912B2 (en) 2018-10-16
US20160015752A1 (en) 2016-01-21
PL2964248T3 (pl) 2019-11-29
EP2964248A2 (en) 2016-01-13
GB201304041D0 (en) 2013-04-17
ES2742851T3 (es) 2020-02-17
CN105120882A (zh) 2015-12-02
HK1218722A1 (zh) 2017-03-10
HRP20191490T1 (hr) 2019-11-15
WO2014135622A2 (en) 2014-09-12
HUE045730T2 (hu) 2020-01-28
SI2964248T1 (sl) 2019-10-30
CA2903647C (en) 2020-06-23
PT2964248T (pt) 2019-09-04
EP2964248B1 (en) 2019-05-22
US11850265B2 (en) 2023-12-26
LT2964248T (lt) 2019-09-10
AU2014224619B2 (en) 2018-03-22
CY1122640T1 (el) 2021-03-12
US20210008116A1 (en) 2021-01-14
AU2014224619A1 (en) 2015-10-08
US20180264042A1 (en) 2018-09-20

Similar Documents

Publication Publication Date Title
DK3043784T3 (da) Arylethere og anvendelser deraf
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
DK3089994T3 (da) Fabs-in-tandem-immunglobulin og anvendelser deraf
DK3035926T3 (da) Forbindelser og fremgangsmåder til behandling af en epilepsilidelse
DK2968208T3 (da) Behandling af kataplexi
IL240388A0 (en) Methods of treating melanoma
DK3052485T3 (da) Heterocykliske forbindelser og anvendelser deraf
DK3777595T3 (da) Integrerede lukkeanordningskomponenter og fremgangsmåder
DK2968443T3 (da) Hepcidinanaloger og anvendelser deraf
HK1222994A1 (zh) 烟草處理
DK3030323T3 (da) Kdm1a-inhibitorer til behandlingen af sygdom
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
DK2970460T3 (da) Anti-IL-33-antistoffer og anvendelser deraf
EP3620203C0 (en) VASCULAR TREATMENT DEVICES
DK3381917T3 (da) Imidazopyridinforbindelser og anvendelser deraf
DK3076976T3 (da) Fremgangsmåder til behandling af cancer
DK2968173T3 (da) Heterocykliske forbindelser og anvendelser deraf
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
DK3021838T3 (da) Behandling af fedme
DK2994533T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK3030549T3 (da) Pyridazinonforbindelser og anvendelser deraf
DK2986722T3 (da) Manipulerede phenylalaninammoniak-lyasepolypeptider
DK3003117T3 (da) Videolaryngoskop og laryngoskopindføringsdel
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK2964767T3 (da) Toksingener og fremgangsmåder til anvendelse deraf